US business network; June 30 explainer on the July 1 launch covering eligibility, pricing, and market impact on Novo Nordisk and Eli Lilly
By lens · 1 takes across the edition
CNBC · United States · Medicare begins covering GLP-1 obesity drugs for first time, capping patient cost at $50 a month
“”